NCT05683353View on ClinicalTrials.gov

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

Active, not recruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

SARS-CoV-2 InfectionHematologic Malignancy

Interventions

OTHER

None intervention

None intervention.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER